๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

25 recruiting trials

for Allogeneic Hematopoietic Cell Transplantation (HCT)

Ziftomenib Maintenance Post Allo-HCT NCT06440135Phase 12 sites๐Ÿ“ Boston๐Ÿ“ Columbus Massachusetts General Hospital ยท Tests: Ziftomenib A Study of Immune Suppression Treatment for People With Sickle Cell Disease or ฮฒ-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT) NCT05736419Phase 26 sites๐Ÿ“ Basking Ridge๐Ÿ“ Middletown๐Ÿ“ Montvale Memorial Sloan Kettering Cancer Center ยท Tests: Fludarabine, Cyclophosphamide, Tacrolimus, Mycophenolate Mofetil, Rabbit ATG Blinatumomab After TCR Alpha Beta/CD19 Depleted HCT NCT04746209Phase 21 site๐Ÿ“ Milwaukee Medical College of Wisconsin ยท Tests: Alpha/Beta T-cell and B-cell depleted HCT, Blinatumomab Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome NCT07582172Phase 21 site๐Ÿ“ Duarte City of Hope Medical Center ยท Tests: Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography, Echocardiography Test, Fludarabine Phosphate HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant NCT03326921Phase 11 site๐Ÿ“ Seattle Fred Hutchinson Cancer Center ยท Tests: CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR, Bone Marrow Aspiration, Biospecimen Collection TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT NCT07302776Phase 11 site๐Ÿ“ Palo Alto Stanford University ยท Tests: Tacrolimus, Early Tacrolimus Taper Strategy Momelotinib During and After HCT in Myelofibrosis NCT07104799Phase 11 site๐Ÿ“ Boston Massachusetts General Hospital ยท Tests: Momelotinib MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib NCT07463651Phase 32 sites๐Ÿ“ Suzhou๐Ÿ“ Shanghai The First Affiliated Hospital of Soochow University ยท Tests: Gilteritinib, Sorafenib A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT NCT07387367Phase 381 sites๐Ÿ“ Phoenix๐Ÿ“ Duarte๐Ÿ“ Palo Alto SymBio Pharmaceuticals ยท Tests: cidofovir, Brincidofovir Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT NCT05429632Phase 3111 sites๐Ÿ“ Birmingham๐Ÿ“ Gilbert๐Ÿ“ Duarte Priothera SAS ยท Tests: mocravimod Post-transplantation Maintenance Therapy With Cidabenamide in Patients With Intermediate/High-risk AML NCT07304232Phase 25 sites๐Ÿ“ Shijiazhuang๐Ÿ“ Harbin๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Chidamide Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation NCT06649201n/a1 site๐Ÿ“ Cleveland Case Comprehensive Cancer Center ยท Tests: Vulvovaginal Symptom Questionnaire, Vaginal Microbiome Evaluation Vitamin A and D Supplementation in Allogeneic HCT NCT06508099Phase 21 site๐Ÿ“ Saint Petersburg St. Petersburg State Pavlov Medical University ยท Tests: Vitamin A, Vitamin D3 Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen NCT06532084Phase 21 site๐Ÿ“ Saint Petersburg St. Petersburg State Pavlov Medical University ยท Tests: Sorafenib Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT NCT06551584Phase 11 site๐Ÿ“ Palo Alto Stanford University ยท Tests: ORCA-T Intraoral Photobiomodulation Therapy to Prevent Oral Mucositis in Patients Undergoing Hematopoietic Cell Transplantation NCT05335434NA1 site๐Ÿ“ Boston Dana-Farber Cancer Institute ยท Tests: THOR LX2.3 with LED Lollipop Ivosidenib as Post-HSCT Maintenance for AML NCT06707493Phase 27 sites๐Ÿ“ Atlanta๐Ÿ“ Kansas City๐Ÿ“ Boston Massachusetts General Hospital ยท Tests: Ivosidenib, Placebo A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant NCT07359859Phase 27 sites๐Ÿ“ Basking Ridge๐Ÿ“ Middletown๐Ÿ“ Montvale Memorial Sloan Kettering Cancer Center ยท Tests: Cyclophosphamide, Cyclophosphamide, Mycophenolate Mofetil, Ruxolitinib, Tacrolimus Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer NCT07046078Phase 21 site๐Ÿ“ Seattle Fred Hutchinson Cancer Center ยท Tests: Allogeneic Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy,โ€ฆ A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy NCT03394365Phase 371 sites๐Ÿ“ Duarte๐Ÿ“ La Jolla๐Ÿ“ Loma Linda Pierre Fabre Medicament ยท Tests: tabelecleucel The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL NCT03509961Phase 224 sites๐Ÿ“ Birmingham๐Ÿ“ Phoenix๐Ÿ“ Duarte Pediatric Transplantation & Cellular Therapy Consortium ยท Tests: NGS-MRD, Myeloablative allogeneic HCT with a non-TBI conditioning regimen Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT NCT03665675EARLY Phase 12 sites๐Ÿ“ Columbus๐Ÿ“ Columbus Sumithira Vasu ยท Tests: Allogeneic Cytomegalovirus-Specific Cytotoxic T lymphocytes, Allogeneic Adenovirus-specific Cytotoxic T Lymphocytes Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma NCT07225985Phase 1, Phase 21 site๐Ÿ“ Seattle Fred Hutchinson Cancer Center ยท Tests: Bendamustine, Pralatrexate, Bone Marrow Aspiration, Bone Marrow Biopsy, Chest Radiography Dapagliflozin in Allo-HCT for aGVHD NCT06626737Phase 21 site๐Ÿ“ Suzhou The First Affiliated Hospital of Soochow University ยท Tests: Dapagliflozin (DAPA) Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ... NCT05470491Phase 1, Phase 21 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: RIC, GVHD prophylaxis, allo HCT, Plerixafor, Maraviroc
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy